Genomic Innovator Award (R35 Clinical Trial Optional) - 0 views
-
MiamiOH OARS on 07 Aug 18This program supports highly creative individuals in NHGRI priority research areas, such as the development of resources, approaches, or technologies that will accelerate genomic research on the structure of genomes, the biology of genomes, or the biology of disease; that will advance the science of genomic medicine; that will incorporate genomics to improve the effectiveness of healthcare; or that will advance genomic technology development, computational genomics, or research on the ethical, legal, and societal implications of genomics and genetics research. This program supports the development of approaches that can be used broadly. A hallmark of genomic research is comprehensiveness across the genome, such as all genes, variants, or regulatory elements, rather than specific sets. The focus should be on developing approaches that can be applied generally, although an approach may be tested with specific genes, genomic elements, variants, cell types, diseases, traits, or model organisms. Studies that focus on one or a few specific genes should be paradigm-setting and yield findings relevant at the genomic level. The application should explain how broadly useful the approaches will be.